Skip to main content
Premium Trial:

Request an Annual Quote

The Low-Down on AACC

Our sister blog, The Sample, is hard at work covering the AACC annual meeting. Kirell Lakhman has a series of posts up and from Friday's session, he writes about new molecular techs flocking to pharma and linking oxaliplatin toxicity to the glutathione S-transferase gene. Yesterday, Lakhman blogged about what molecular diagnostic labs should keep in mind when trying to quantify serum tumor markers using LC-MS/MS and how revamping the US health care system may affect clinical labs. Lakhman is also noting interesting quotes he's heard, such as the University of Washington's Andrew Hoofnagle saying the software bundle to a mass spec "can be testy at times." If you've heard anything good, let him know.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.